Cord Blood Banking Market size was valued USD 27.29 billion in 2024 and is anticipated to reach USD 47.59 billion by 2032, at a CAGR of 7.2% during the forecast period.
REPORT ATTRIBUTE
DETAILS
Historical Period
2020-2023
Base Year
2024
Forecast Period
2025-2032
Cord Blood Banking Market Size 2024
USD 27.29 Billion
Cord Blood Banking Market, CAGR
7.2%
Cord Blood Banking Market Size 2032
USD 47.59 Billion
The cord blood banking market is driven by top players including Cryo-Cell International, AlphaCord LLC, Cord Blood Foundation (Smart Cells International), CBR Systems Inc., Singapore Cord Blood Bank, California Cryobank Stem Cell Services LLC, Cordlife Group Limited, FamiCord, Global Cord Blood Corporation, and CSG-BIO. These companies focus on technological advancements, strategic partnerships, and expanding their global service networks to strengthen market positions. They invest heavily in automated processing systems and cryopreservation innovations to enhance stem cell viability. North America leads the global market with a 38% share, supported by advanced healthcare infrastructure, strong research investments, and high parental awareness. This leadership is reinforced by extensive clinical trials and favorable reimbursement frameworks that encourage higher participation in both public and private banking programs.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
The Cord Blood Banking Market was valued at USD 27.29 billion in 2024 and is expected to reach USD 47.59 billion by 2032, growing at a CAGR of 7.2%.
Rising demand for regenerative therapies, growing clinical research, and increasing parental awareness are driving strong market expansion globally.
Technological innovations in automated processing and cryopreservation are creating new opportunities, supported by strategic collaborations between public and private banking institutions.
Intense competition among key players is shaping the market, with companies focusing on infrastructure expansion, service diversification, and international partnerships to strengthen their positions.
North America dominates with a 38% share, followed by Europe at 27% and Asia Pacific at 23%, while public banks hold a larger segment share due to government support and higher donor participation.
Market Segmentation Analysis:
By Storage Services
Private cord blood banks hold the dominant market share. Rising awareness of personalized medicine and increasing preference for family stem cell storage drive this segment. Families choose private banks for exclusive access to stored stem cells, enabling future therapeutic use for genetic or acquired conditions. The availability of flexible storage plans, advanced cryopreservation technology, and improved collection logistics further strengthen adoption. Public banks continue to play a vital role in donor availability and research support, but private services lead due to rising consumer demand for individualized healthcare solutions.
For instance, Cryo-Cell reports independent sources confirm that stem cells can lose viability and function if exposed to temperatures outside the 4–30 °C range (39–86 °F) during transportation.
By Component
Cord blood remains the dominant component segment, holding the highest market share. This dominance is driven by the established clinical applications of cord blood stem cells in treating hematologic and immune disorders. Cord blood offers easier collection, higher stem cell concentration, and lower rejection risk in transplants. Ongoing R&D expands its therapeutic applications, further boosting demand. Cord tissue is gaining traction for its regenerative potential, especially in orthopedics and neurological conditions. Its growing use in regenerative therapies positions it as a key future growth segment.
For instance, AlphaCord, part of the CSG. BIO Group, is a provider of cord blood and tissue banking services. The CSG. BIO Group, as a whole, has processed and stored over 750,000 samples in its database.
By Application
Cancer disease applications lead the market, holding the dominant share. Cord blood stem cells are widely used in treating leukemia, lymphoma, and other blood cancers due to their high efficacy and lower graft-versus-host risks. Advancements in transplant success rates and supportive clinical guidelines drive adoption in oncology. Immune and blood disorders also represent significant segments, supported by rising transplant procedures worldwide. Diabetes and metabolic disorders are emerging applications, benefiting from ongoing clinical trials exploring the potential of cord tissue-derived stem cells in regenerative medicine.
Key Growth Drivers
Rising Prevalence of Chronic Diseases
The growing incidence of cancer, immune disorders, and blood diseases is driving demand for cord blood banking. Cord blood stem cells offer effective treatment options for conditions like leukemia and lymphoma. Medical research continues to expand clinical applications, increasing patient awareness and adoption. Public and private banks are investing in infrastructure to meet rising collection volumes. The higher success rate of stem cell transplants from cord blood compared to bone marrow strengthens market growth. This expanding therapeutic potential remains a strong growth catalyst.
For instance, CBR has reported the release of more than 750 cord-blood units for clinical or investigational use by end of 2024, with 84% of those intended for regenerative-medicine applications.
Expanding Clinical Research and Trials
Ongoing clinical trials exploring regenerative therapies are creating new opportunities for cord blood banking. Researchers are studying stem cells for treating diabetes, metabolic disorders, and neurological diseases. Collaborations between biotech firms and medical institutions are improving cryopreservation and stem cell expansion technologies. These developments increase the clinical utility of stored cord blood. Regulatory approvals for advanced therapies further support adoption. The rising number of government-backed research programs also accelerates market expansion across developed and emerging economies.
For instance, Cordlife Group Limited — The company records having processed and stored more than 400,000 cord blood, cord lining, cord tissue and placenta stem-cell units across its network.
Growing Awareness and Parental Enrollment
Increasing awareness among expectant parents about the medical benefits of cord blood banking boosts market demand. Educational campaigns and partnerships with maternity hospitals make collection more accessible. Many private cord blood banks offer flexible payment and storage options, encouraging higher enrollment rates. The growth of personalized medicine further highlights the importance of biological resource preservation. This growing awareness leads to higher participation in both public and private banking programs, strengthening the overall market outlook.
Key Trends & Opportunities
Technological Advancements in Cryopreservation
Innovations in cryopreservation techniques are improving the quality and viability of stored cord blood units. Automated processing systems enhance cell recovery rates, reducing contamination risks. Integration of AI-driven quality control helps banks maintain standardized storage protocols. Improved storage efficiency lowers operational costs for banks, boosting profitability. These advancements make long-term storage more reliable, encouraging wider participation in banking programs. The continued focus on quality assurance opens opportunities for technology providers and service expansion.
For instance, FamiCord reports that its facilities currently store more than 1,000,000 biological samples, encompassing umbilical cord blood, cord tissue and placenta units.
Increasing Public-Private Collaborations
Governments and private institutions are forming strategic collaborations to strengthen cord blood infrastructure. Public banking initiatives expand access for patients needing transplants, while private players contribute funding and innovation. Joint programs enhance donor diversity, increasing the chances of successful matches. Such partnerships also support broader awareness campaigns and standardization of collection protocols. These efforts improve healthcare access and promote sustained market growth. This trend creates new investment and innovation opportunities in the sector.
For instance, Global Cord Blood Corporation reported that by March 2022 its inventory across family bank subscribers and public bank donors reached 1,060,516 cord blood units.
Emergence of Regenerative Medicine Applications
Regenerative medicine is expanding the therapeutic potential of cord blood. Stem cells are increasingly used in clinical trials for cardiovascular and neurological disorders. This widening application range drives demand for high-quality storage solutions. Pharmaceutical and biotech companies are investing in new research programs to commercialize advanced therapies. The convergence of cord blood banking with regenerative medicine strengthens long-term market opportunities and positions the sector for sustained expansion.
Key Challenges
High Cost of Private Banking
The high cost of collection, processing, and long-term storage limits the adoption of private banking. Many families in low- and middle-income countries cannot afford the fees, restricting market penetration. Even in developed regions, cost remains a factor influencing parental decisions. Public banks often offer free storage but face capacity constraints. Addressing pricing models and expanding insurance coverage are essential to overcome this challenge. Cost reduction strategies will be critical for wider market accessibility.
Limited Awareness in Emerging Economies
In many developing countries, awareness of cord blood banking remains low. Limited education about its medical applications reduces parental participation rates. Inadequate infrastructure and lack of trained healthcare professionals further constrain collection efforts. Cultural factors also influence donation decisions in some regions. Expanding educational campaigns and healthcare partnerships can help bridge this gap. Overcoming this awareness challenge is crucial for unlocking growth potential in high-population markets.
Regional Analysis
North America
North America leads the cord blood banking market with a 38% share, driven by advanced healthcare infrastructure and high parental awareness. The U.S. dominates the region due to strong public and private banking programs and favorable reimbursement policies. Extensive research activities and clinical trials for regenerative therapies support sustained market expansion. Major players invest heavily in advanced processing and cryopreservation technologies. Strong government support and established regulatory frameworks enhance patient trust and participation. The region also benefits from widespread insurance coverage, enabling more families to access cord blood storage services.
Europe
Europe holds a 27% share of the cord blood banking market, supported by well-structured public banking systems and increasing clinical applications. Countries like Germany, the U.K., and France lead adoption through strong research investments and collaborative healthcare networks. EU-funded programs encourage donations and improve cross-border stem cell matching capabilities. Favorable regulations and ethical standards strengthen parental confidence in banking services. Expanding regenerative medicine trials across the region further drive market growth. Public-private partnerships and growing awareness campaigns continue to boost enrollment rates in both public and private banks.
Asia Pacific
Asia Pacific accounts for a 23% share of the cord blood banking market, propelled by growing healthcare investments and rapid urbanization. Countries such as China, India, Japan, and South Korea are witnessing rising parental enrollment due to increasing awareness of stem cell therapies. Governments are expanding infrastructure through public banking initiatives, while private companies offer affordable storage plans. Advancements in biotechnology and rising demand for regenerative treatments fuel market expansion. The region’s large birth rate base further strengthens its growth potential. Ongoing regulatory harmonization supports cross-border collaborations and enhances access to services.
Latin America
Latin America captures a 7% share of the cord blood banking market, with Brazil and Mexico leading adoption. The region is witnessing gradual infrastructure development, supported by government programs and private investments. Public awareness remains lower compared to developed markets but is steadily improving through targeted campaigns. Expanding partnerships with international stem cell organizations enhance service quality. Economic constraints remain a challenge, but affordable storage plans are increasing parental participation. The rising incidence of chronic diseases such as leukemia and immune disorders is boosting demand for cord blood storage services.
Middle East & Africa
The Middle East & Africa hold a 5% share of the global cord blood banking market. Growth is primarily driven by improving healthcare infrastructure in the Gulf countries and South Africa. Government initiatives and medical tourism support increased adoption of advanced treatments. Private banks are expanding their presence through partnerships with hospitals and fertility clinics. However, limited awareness and high costs remain key barriers in several African countries. Increasing investments in research and the growing prevalence of genetic and blood-related disorders are expected to create future growth opportunities in the region.
Market Segmentations:
By Storage Services:
Public Cord Blood Banks
Private Cord Blood Banks
By Component:
Cord Blood
Cord Tissue
By Application:
Cancer Disease
Diabetes
By Geography
North America
U.S.
Canada
Europe
Germany
France
Italy
U.K.
Russia
Rest of Europe
Asia-Pacific
India
China
Japan
Rest of Asia-Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC Countries
South Africa
Rest of Middle East and Africa
Competitive Landscape
The competitive landscape of the cord blood banking market is shaped by Cryo-Cell International, AlphaCord LLC, Cord Blood Foundation (Smart Cells International), CBR Systems Inc., Singapore Cord Blood Bank, California Cryobank Stem Cell Services LLC, Cordlife Group Limited, FamiCord, Global Cord Blood Corporation, and CSG-BIO. The cord blood banking market is characterized by rapid technological innovation, strategic partnerships, and expanding service portfolios. Companies focus on enhancing cryopreservation methods, automated processing systems, and stem cell expansion technologies to strengthen their positions. Many market participants are investing in clinical research to support broader therapeutic applications in regenerative medicine. Geographic expansion and collaborations with maternity hospitals help increase collection volumes and customer enrollment. Flexible payment models, digital platforms, and strong brand positioning further support growth. Intense competition drives continuous improvement in quality standards, operational efficiency, and accessibility of cord blood banking services worldwide.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
In May 2025, Terumo Blood and Cell Technologies confirmed that Parachute Health adopted Rika Plasma Donation System, enabling 1,000 mL plasma collections in under 35 minutes with live donor-comfort analytics.
In February 2024, CooperSurgical®, a global leader in fertility and women’s health, and Fulgent Genetics, Inc., a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, announced that they have partnered to offer families of Cord Blood Registry® (CBR®) exclusive newborn genetic screening panels.
In July 2023, Cell Genesis announced the launch of CEXCI Cord Protein Banking, a groundbreaking initiative that marks a new era in the field of stem cell research and personalized medicine.
In May 2023, Terumo BCT introduced a next-generation platform, the Spectra Optia Apheresis System. This system is designed to improve patient care and streamline workflow in blood processing. This innovative system offers advanced features that improve the efficiency of apheresis procedures, allowing for better separation of blood components.
Report Coverage
The research report offers an in-depth analysis based on Storage Services, Component, Application and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook
Demand for regenerative therapies will significantly boost cord blood banking adoption.
Advancements in cryopreservation will enhance stem cell quality and storage efficiency.
Public and private banking collaborations will increase global accessibility.
Rising parental awareness will drive higher enrollment rates across regions.
Clinical research expansion will unlock new therapeutic applications.
Digital platforms will streamline donor registration and storage management.
Emerging markets will contribute strongly to overall industry growth.
Regulatory harmonization will improve international stem cell exchange.
Strategic investments will strengthen infrastructure and processing capabilities.
Personalized medicine trends will increase long-term storage demand.
1. Introduction
1.1. Report Description
1.2. Purpose of the Report
1.3. USP & Key Offerings
1.4. Key Benefits for Stakeholders
1.5. Target Audience
1.6. Report Scope
1.7. Regional Scope
2. Scope and Methodology
2.1. Objectives of the Study
2.2. Stakeholders
2.3. Data Sources
2.3.1. Primary Sources
2.3.2. Secondary Sources
2.4. Market Estimation
2.4.1. Bottom-Up Approach
2.4.2. Top-Down Approach
2.5. Forecasting Methodology
3. Executive Summary
4. Introduction
4.1. Overview
4.2. Key Industry Trends
5. Global Cord Blood Banking Market
5.1. Market Overview
5.2. Market Performance
5.3. Impact of COVID-19
5.4. Market Forecast
6. Market Breakup by Storage Services
6.1. Public Cord Blood Banks
6.1.1. Market Trends
6.1.2. Market Forecast
6.1.3. Revenue Share
6.1.4. Revenue Growth Opportunity
6.2. Private Cord Blood Banks
6.2.1. Market Trends
6.2.2. Market Forecast
6.2.3. Revenue Share
6.2.4. Revenue Growth Opportunity
7. Market Breakup by Component
7.1. Cord Blood
7.1.1. Market Trends
7.1.2. Market Forecast
7.1.3. Revenue Share
7.1.4. Revenue Growth Opportunity
7.2. Cord Tissue
7.2.1. Market Trends
7.2.2. Market Forecast
7.2.3. Revenue Share
7.2.4. Revenue Growth Opportunity
8. Market Breakup by Application
8.1. Cancer Disease
8.1.1. Market Trends
8.1.2. Market Forecast
8.1.3. Revenue Share
8.1.4. Revenue Growth Opportunity
8.2. Diabetes
8.2.1. Market Trends
8.2.2. Market Forecast
8.2.3. Revenue Share
8.2.4. Revenue Growth Opportunity
9. Market Breakup by Region
9.1. North America
9.1.1. United States
9.1.1.1. Market Trends
9.1.1.2. Market Forecast
9.1.2. Canada
9.1.2.1. Market Trends
9.1.2.2. Market Forecast
9.2. Asia-Pacific
9.2.1. China
9.2.2. Japan
9.2.3. India
9.2.4. South Korea
9.2.5. Australia
9.2.6. Indonesia
9.2.7. Others
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. United Kingdom
9.3.4. Italy
9.3.5. Spain
9.3.6. Russia
9.3.7. Others
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Others
9.5. Middle East and Africa
9.5.1. Market Trends
9.5.2. Market Breakup by Country
9.5.3. Market Forecast
10. SWOT Analysis
10.1. Overview
10.2. Strengths
10.3. Weaknesses
10.4. Opportunities
10.5. Threats
11. Value Chain Analysis
12. Porter’s Five Forces Analysis
12.1. Overview
12.2. Bargaining Power of Buyers
12.3. Bargaining Power of Suppliers
12.4. Degree of Competition
12.5. Threat of New Entrants
12.6. Threat of Substitutes
13. Price Analysis
14. Competitive Landscape
14.1. Market Structure
14.2. Key Players
14.3. Profiles of Key Players
14.3.1. Cryo-Cell International
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. Financials
14.3.1.4. SWOT Analysis
14.3.2. AlphaCord LLC
14.3.2.1. Company Overview
14.3.2.2. Product Portfolio
14.3.2.3. Financials
14.3.2.4. SWOT Analysis
14.3.3. Cord Blood Foundation (Smart Cells International)
14.3.3.1. Company Overview
14.3.3.2. Product Portfolio
14.3.3.3. Financials
14.3.3.4. SWOT Analysis
14.3.4. CBR Systems Inc.
14.3.4.1. Company Overview
14.3.4.2. Product Portfolio
14.3.4.3. Financials
14.3.4.4. SWOT Analysis
14.3.5. Singapore Cord Blood Bank
14.3.5.1. Company Overview
14.3.5.2. Product Portfolio
14.3.5.3. Financials
14.3.5.4. SWOT Analysis
14.3.6. California Cryobank Stem Cell Services LLC
14.3.6.1. Company Overview
14.3.6.2. Product Portfolio
14.3.6.3. Financials
14.3.6.4. SWOT Analysis
14.3.7. Cordlife Group Limited
14.3.7.1. Company Overview
14.3.7.2. Product Portfolio
14.3.7.3. Financials
14.3.7.4. SWOT Analysis
14.3.8. FamiCord
14.3.8.1. Company Overview
14.3.8.2. Product Portfolio
14.3.8.3. Financials
14.3.8.4. SWOT Analysis
14.3.9. Global Cord Blood Corporation
14.3.9.1. Company Overview
14.3.9.2. Product Portfolio
14.3.9.3. Financials
14.3.9.4. SWOT Analysis
14.3.10. CSG-BIO
14.3.10.1. Company Overview
14.3.10.2. Product Portfolio
14.3.10.3. Financials
14.3.10.4. SWOT Analysis
15. Research Methodology
Request A Free Sample
We prioritize the confidentiality and security of your data. Our promise: your information remains private.
Ready to Transform Data into Decisions?
Request Your Sample Report and Start Your Journey of Informed Choices
Providing the strategic compass for industry titans.
Frequently Asked Questions
What is the current market size for Cord Blood Banking Market, and what is its projected size in 2032?
The market size was valued at USD 27.29 billion in 2024 and is projected to reach USD 47.59 billion by 2032.
At what Compound Annual Growth Rate is the Cord Blood Banking Market projected to grow between 2025 and 2032?
The market is expected to grow at a CAGR of 7.2% during the forecast period.
Which Cord Blood Banking Market segment held the largest share in 2024?
The private cord blood banking segment held the largest share, driven by rising personalized medicine demand.
What are the primary factors fueling the growth of the Cord Blood Banking Market?
Key factors include rising chronic disease prevalence, expanding clinical research, and growing parental awareness.
Who are the leading companies in the Cord Blood Banking Market?
Major companies include Cryo-Cell International, AlphaCord LLC, CBR Systems Inc., Cordlife Group Limited, and Global Cord Blood Corporation.
Which region commanded the largest share of the Cord Blood Banking Market in 2024?
North America led the market with a 38% share, supported by advanced healthcare infrastructure and strong research investment.
About Author
Shweta Bisht
Healthcare & Biotech Analyst
Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.
The Global Pharmaceutical Packaging Market size was valued at USD 1,29,838.2 million in 2018 to USD 1,76,976.7 million in 2024 and is anticipated to reach USD 3,88,236.7 million by 2032, at a CAGR of 10.39% during the forecast period.
The Global Opioid Drugs Market size was valued at USD 15,712.5 million in 2018 to USD 22,518.0 million in 2024 and is anticipated to reach USD 38,293.0 million by 2032, at a CAGR of 6.92% during the forecast period.
The Gaucher Disease Drugs market was valued at USD 1.71 billion in 2024 and is projected to reach USD 2.01 billion by 2032, growing at a CAGR of 2.1% during the forecast period.
The Doxorubicin market was valued at USD 1.8 billion in 2024 and is projected to reach USD 2.6 billion by 2032, growing at a CAGR of 4.7% during the forecast period.
The Dopamine Agonists market was valued at USD 1.4 billion in 2024 and is projected to reach USD 2.44 billion by 2032, growing at a CAGR of 7.2% during the forecast period.
The Latin America Retail Pharmacy Market size was valued at USD 54,202.26 million in 2018 to USD 65,793.78 million in 2024 and is anticipated to reach USD 83,665.54 million by 2032, at a CAGR of 2.84% during the forecast period.
Germany Compounding Pharmacies Market size was valued at USD 381.95 Million in 2018, growing to USD 535.21 Million in 2024, and is anticipated to reach USD 829.32 Million by 2032, at a CAGR of 5.24% during the forecast period.
Italy Compounding Pharmacies Market size was valued at USD 267.42 Million in 2018, growing to USD 379.23 Million in 2024, and is anticipated to reach USD 597.97 Million by 2032, at a CAGR of 5.45% during the forecast period.
Japan Compounding Pharmacies Market size was valued at USD 142.60 million in 2018 and increased to USD 221.90 million in 2024. The market is anticipated to reach USD 403.45 million by 2032, growing at a CAGR of 7.23% during the forecast period.
The Fondaparinux market size was valued at USD 686.65 million in 2024 and is anticipated to reach USD 1,107.44 million by 2032, growing at a CAGR of 6.3% during the forecast period.
U.S. Compounding Pharmacies market size was valued at USD 3,293.81 Million in 2018, rising to USD 4,743.43 Million in 2024, and is anticipated to reach USD 7,651.56 Million by 2032, growing at a CAGR of 5.73% during the forecast period.
The UK Compounding Pharmacies market was valued at USD 173.65 million in 2018 and grew to USD 237.16 million in 2024. The market is projected to reach USD 354.16 million by 2032, registering a CAGR of 4.79% during the forecast period.
Licence Option
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$4999
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$6999
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.
Materials Scientist (privacy requested)
The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.
